Total Funding
$3.3M
Employee Range
1-10
Eversyn, a spin-off of the Max Planck Institute Magdeburg, utilizes cutting-edge technology developed by former Max Planck scientists to create GMO-free biocatalytic cascades. Their innovative approach is revolutionizing the biotech industry.
eversyn data powered by:
Share
eversyn data powered by:
eversynOverall Ranking
Regional Rank
Share
Loading...
In Western Europe
Top null%out of startups
eversynIndustry Rankings in
Healthtech
City Rank
Share
3rd
In Magdeburg
Top 38%out of 8 startups
National Rank
Share
254th
In Germany
Top 54%out of 472 startups
Regional Rank
Share
2,563rd
In Western Europe
Top 57%out of 4549 startups
eversynSubindustry Rankings in
BiotechnologyCity Rank
Share
1st
In Magdeburg
Top 100%out of 1 startups
National Rank
Share
88th
In Germany
Top 62%out of 142 startups
Regional Rank
Share
1,142nd
In Western Europe
Top 67%out of 1726 startups
rankings by:
eversynSB Rank Evolution
Not enough data points to display the chart.
eversynstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro